HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 425 filers reported holding HALOZYME THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.31 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $24 | -27.3% | 615 | -33.3% | 0.02% | -28.0% |
| Q2 2023 | $33 | +200.0% | 922 | +223.5% | 0.02% | +150.0% |
| Q1 2023 | $11 | -90.8% | 285 | -86.5% | 0.01% | -79.6% |
| Q4 2022 | $120 | -99.8% | 2,106 | +19.1% | 0.05% | -21.0% |
| Q3 2022 | $70,000 | +133.3% | 1,768 | +159.6% | 0.06% | +158.3% |
| Q2 2022 | $30,000 | -54.5% | 681 | -59.0% | 0.02% | -45.5% |
| Q1 2022 | $66,000 | -42.1% | 1,661 | -41.2% | 0.04% | -72.5% |
| Q4 2021 | $114,000 | – | 2,827 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Third Security, LLC | 1,129,551 | $47,091,000 | 6.38% |
| First Light Asset Management, LLC | 2,011,350 | $83,853,000 | 5.56% |
| TRAN CAPITAL MANAGEMENT, L.P. | 1,353,208 | $56,415,000 | 5.03% |
| SNYDER CAPITAL MANAGEMENT L P | 2,920,860 | $121,771,000 | 3.50% |
| DOHENY ASSET MANAGEMENT /CA | 120,028 | $5,004,000 | 3.39% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 104,945 | $4,375,000 | 2.39% |
| Redwood Investments, LLC | 542,764 | $22,628,000 | 1.99% |
| Kent Lake Capital LLC | 85,000 | $3,544,000 | 1.44% |
| Lisanti Capital Growth, LLC | 263,460 | $10,984,000 | 1.41% |
| Bellevue Group AG | 3,011,966 | $125,569,000 | 1.33% |